Skip to main content

Table 2 Patient Characteristics

From: Development and validation of sensitive BCR::ABL1 fusion gene quantitation using next-generation sequencing

Characteristics

 

Patients (n = 77)a

Age (Years)

 

55 (9–81; 43–62)

Sex

  
 

Male

44 (57%)

 

Female

33 (43%)

Diagnosis

  
 

CML-CP

72 (93.5%)

 

CML-AP

2 (2.6%)

 

CML-BP

1 (1.3%)

 

BLL

2 (2.6%)

Transcript type

  
 

e14a2

50 (64.9%)

 

e13a2

17 (22.1%)

 

e14a2 or e13a2

10 (13.0%)

  1. aData are median (range; IQR) or n (%)